Day: March 31, 2026

11223344556677PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS)A multi-million-euro investment that strengthens Belgium’s and Europe’s defense industrial base Production of IRIS-C thermal imaging clip-on systems in Zaventem for the Belgian and German Armed Forces under the OCCAR framework contract from 2025 Local industrial participation and partnerships with Belgian manufacturers support supply chain resilience, create tech-driven jobs, and enhance national and European production defense capacity31 March 2026, Belgium. THEON International Plc inaugurated its 100% owned subsidiary THEON Belgium and its state-of-the-art production facility in Zaventem, in the presence of Belgian Minister of Defense Theo Francken, marking a significant step in the Company’s European...

New Integration Expands EzFill Platform with Gopuff-Powered Delivery of 5,000+ Products, Creating a Seamless New Revenue Channel for NextNRG MIAMI, FL , March 31, 2026 (GLOBE NEWSWIRE) — NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered, today announced the launch of EzShop within its EzFill mobile fueling platform, a new shopping experience powered by Gopuff, a leader in instant commerce. Through EzShop, customers can order from more than 5,000 everyday essentials alongside their fuel delivery, all from a single app. Launching in select EzFill markets in Q2 2026, EzShop will give customers the ability to shop more than 5,000 affordably priced everyday essentials, including groceries, snacks, beverages, household items, and OTC medications, and automotive...

Potential breakthrough therapeutic targets $50B+ global immunotherapy market1 CHICAGO, March 31, 2026 (GLOBE NEWSWIRE) — MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced highlights from a poster presented on March 27, 2026, at the European Lung Cancer Congress 2026 (ELCC), a premier thoracic oncology forum held March 25-28, 2026, in Copenhagen, Denmark. MAIA reports overall survival (OS) beyond two years for eight patients treated with ateganosine sequenced with cemiplimab in Parts A and B of its ongoing Phase 2 THIO-101 clinical trial in non-small cell lung cancer (NSCLC). The patients did not receive subsequent lines of therapy. The eight patients featured in the poster include:1 patient...

LAS VEGAS, March 31, 2026 (GLOBE NEWSWIRE) — Innovative Payment Solutions, Inc. (OTC: IPSI) (“IPSI” or the “Company”) today announced that its wholly owned subsidiary, Astria Insurance Solutions Inc. (“AIS”), has reached a key milestone with the generation of its first revenue under its previously announced Marketing & Services Agreement (“MSA”). Following the successful launch of AIS’s insurance marketing platform and services earlier in March 2026, the Company confirms that initial sales have been completed and revenue has been generated. AIS is now expecting to receive its first Software as a Service (“SaaS”) revenue payment, which is anticipated to be deposited into AIS’s account during the first week of April 2026. This milestone represents the first recorded revenue for AIS and marks the beginning of IPSI’s monetization...

AerSale Boeing 757-200 PCFBoeing 757-200 Precision Converted FreighterMIAMI, March 31, 2026 (GLOBE NEWSWIRE) — AerSale Corporation (NASDAQ: ASLE) (the “Company”), a leading global provider of aviation aftermarket products and services, announced the lease of a Boeing 757-200 Precision Converted Freighter (PCF) aircraft to Stratos Freight, an emerging all-cargo airline based in Tashkent, Uzbekistan. Stratos Freight is strategically positioned at the intersection of Asia and Europe, operating along key trade routes connecting China, the Middle East, and Europe. The addition of the Boeing 757-200PCF enhances the airline’s medium-widebody freighter fleet and supports its growing scheduled and charter cargo operations throughout Central Asia and beyond. “The Boeing 757 freighter continues to be a highly versatile and efficient...

JERUSALEM, March 31, 2026 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT® today announced that an abstract presenting results of two clinical trials in Jerusalem in patients with pancreatic cancer has been accepted for an oral presentation at Digestive Disease Week (DDW) 2026, the world’s premier international gastroenterology conference. This marks the first time that clinical results of Alpha DaRT in pancreatic cancer patients have been selected for presentation at a major gastroenterology conference. The abstract, entitled “Updated Results of Feasibility, Safety, and Tumor Control in Two First-In-Human Trials of a Novel Alpha-Emitting Radionuclide for Pancreatic Adenocarcinoma,” has been selected for podium presentation in...

Growing volume of customer engagements and requests for proposals signals strengthening pipeline as company enters execution phase NEW YORK and TEL AVIV, Israel , March 31, 2026 (GLOBE NEWSWIRE) — T3 Defense Inc. (NASDAQ: DFNS) (“T3 Defense” or the “Company”), a holding company that acquires and operates mission-critical defense businesses, today announced an increase in business activity across its portfolio of subsidiaries. While many of these discussions are in the pre-order stage, the Company believes the rising level of engagement reflects a growing recognition of its capabilities across the markets it serves, driven in part by recent geopolitical developments and associated global investments in defense capabilities. The Company reported a rise in requests for proposals (RFPs), inbound potential customer inquiries, and early-stage...

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) — Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp.” or the “Company”), a leading critical mineral mining company, today announced that the historical metallurgical test results done by AMTEC / ALS in 2016 has been successfully replicated in the 2025 test work program undertaken at Fremantle Metallurgy laboratories, Perth, Western Australia, under the review of independent consultant Professor Tony Tang. Professor Tony Tang utilized a duplicate ore sample that was used in the original 2016 Tanbreez study. HighlightsOutstanding 2.96% TREO and HREO refined concentrate Approximate 40% increase over the previous 2.1% TREO refined concentrate results.In December 2025, the Company received the initial assay reports from Fremantle Metallurgical test Work and Independent Laboratory...